The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Replimune Group Inc’s stock clocked out at $8.98, down -4.16% from its previous closing price of $9.37. In other words, the price has decreased by -$4.16 from its previous closing price. On the day, 2.18 million shares were traded.
Ratios:
To gain a deeper understanding of REPL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.95 and its Current Ratio is at 7.95. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on August 28, 2024, initiated with a Buy rating and assigned the stock a target price of $17.
On November 19, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $52.Piper Sandler initiated its Overweight rating on November 19, 2021, with a $52 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when Astley-Sparke Philip sold 32,279 shares for $8.06 per share. The transaction valued at 260,169 led to the insider holds 1,405,071 shares of the business.
Xynos Konstantinos sold 7,952 shares of REPL for $64,093 on May 20 ’25. The Chief Medical Officer now owns 146,933 shares after completing the transaction at $8.06 per share. On May 20 ’25, another insider, Schwendenman Andrew, who serves as the Chief Accounting Officer of the company, sold 3,287 shares for $8.05 each. As a result, the insider received 26,460 and left with 68,284 shares of the company.
Stock Price History:
Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $4.93. The 50-Day Moving Average of the stock is 3.76%, while the 200-Day Moving Average is calculated to be -19.34%.
Shares Statistics:
A total of 77.09M shares are outstanding, with a floating share count of 62.53M. Insiders hold about 18.88% of the company’s shares, while institutions hold 94.56% stake in the company.
